THE PREVALENCE OF POTENTIAL DRUG-DRUG INTERACTIONS IN THE THERAPY OF ROMANIAN COMMUNITY PHARMACY'S PATIENTS

被引：0
|
作者：
Bucsa, Camelia Denisa [1 ]
Cazacu, Irina [1 ]
Farcas, Andreea Maria [1 ]
机构：
[1] Univ Med & Pharm Iuliu Hatieganu, Drug Informat Res Ctr, Fac Pharm, Cluj Napoca, Romania
来源：
FARMACIA | 2012年 / 60卷 / 04期
关键词：
drug-drug interactions; adverse drug reactions; community pharmacy; HOSPITAL ADMISSIONS; ADVERSE; MEDICINE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Drug-drug interactions (DDIs) are a concern for patients and providers, as multiple medication use is becoming more common to manage complex diseases. However, a high prevalence of potential drug-drug interactions (pDDIs) can lead to a higher probability to develop an adverse drug reaction (ADR) or suboptimal therapeutic effects. The objective of our study was to measure the frequency, nature and severity of the potential DDIs in prescriptions from a Romanian community pharmacy. We analysed 308 prescriptions (all reimbursed prescriptions from one month) of 243 patients for the detection of the pDDIs. Our study showed that potential drug-drug interactions are highly prevalent (34.42% of prescriptions with at least one DDI) in patients' therapy and the modernization of prescribing and dispensing medicines is necessary.
引用
收藏
页码：510 / 516
页数：7
相关论文
共 50 条
  • [21] Prevalence of drug-drug interactions in geriatric patients at an ambulatory care pharmacy in a tertiary care teaching hospital
    Aljadani R.
    Aseeri M.
    BMC Research Notes, 11 (1)
  • [22] Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients
    Zhang, Jiali
    Ma, Danyi
    Chen, Meng
    Hu, Yanting
    Chen, Xveying
    Chen, Jingyu
    Huang, Man
    Dai, Haibin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] Polypharmacy in hematology and oncology patients and the resulting prevalence of potential drug-drug interactions (DDI)
    Metzke, B.
    Fink, G.
    Hieke, S.
    Jung, M.
    Hug, M. J.
    Engelhardt, M.
    ONKOLOGIE, 2012, 35 : 76 - 76
  • [24] Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors
    Bibi, Rashida
    Azhar, Saira
    Iqbal, Ayesha
    Jabeen, Hajera
    Kalsoom, Umm-e
    Iqbal, Muhammad M.
    Nazeer, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1616 - 1622
  • [25] Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
    Ismail, Mohammad
    Khan, Sehrash
    Khan, Fahadullah
    Noor, Sidra
    Sajid, Hira
    Yar, Shazia
    Rasheed, Irum
    BMC CANCER, 2020, 20 (01)
  • [26] Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs
    van Leeuwen, R. W. F.
    Brundel, D. H. S.
    Neef, C.
    van Gelder, T.
    Mathijssen, R. H. J.
    Burger, D. M.
    Jansman, F. G. A.
    BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1071 - 1078
  • [27] Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
    Bachmann, Paula
    Frahm, Niklas
    Debus, Jane Louisa
    Mashhadiakbar, Pegah
    Langhorst, Silvan Elias
    Streckenbach, Barbara
    Baldt, Julia
    Heidler, Felicita
    Hecker, Michael
    Zettl, Uwe Klaus
    PHARMACEUTICS, 2022, 14 (03)
  • [28] Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
    Mohammad Ismail
    Sehrash Khan
    Fahadullah Khan
    Sidra Noor
    Hira Sajid
    Shazia Yar
    Irum Rasheed
    BMC Cancer, 20
  • [29] Evaluation of potential drug-drug interactions in psychiatric patients
    Todorova-Nenova, K.
    Zhelyazkova-Savova, M.
    Gancheva, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S258 - S259
  • [30] Analysis of potential drug-drug interactions in psychiatric patients
    Mahesh, N. M.
    Ramesh, M.
    Guptha, Raghunatha A.
    Parthasarathi, G.
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2007, 41 (01) : 28 - 34
12345